Cargando…
Lipid metabolism as a target for cancer drug resistance: progress and prospects
Cancer is the world’s leading cause of human death today, and the treatment process of cancer is highly complex. Chemotherapy and targeted therapy are commonly used in cancer treatment, and the emergence of drug resistance is a significant problem in cancer treatment. Therefore, the mechanism of dru...
Autores principales: | Wang, Zi’an, Wang, Yueqin, Li, Zeyun, Xue, Wenhua, Hu, Shousen, Kong, Xiangzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571713/ https://www.ncbi.nlm.nih.gov/pubmed/37841917 http://dx.doi.org/10.3389/fphar.2023.1274335 |
Ejemplares similares
-
Clinical diagnostic value of amino acids in laryngeal squamous cell carcinomas
por: Hu, Shousen, et al.
Publicado: (2023) -
Progress of potential drugs targeted in lipid metabolism research
por: Liang, Kai, et al.
Publicado: (2022) -
Analysis of lncRNA, miRNA and mRNA-associated ceRNA networks and identification of potential drug targets for drug-resistant non-small cell lung cancer
por: Kong, Xiangzhen, et al.
Publicado: (2020) -
Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma
por: Zheng, Yang, et al.
Publicado: (2023) -
Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization
por: Wu, Tong, et al.
Publicado: (2023)